Ackermann M, Verleden SE, Kuehnel M et al (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med 383:120–128. https://doi.org/10.1056/NEJMoa2015432

Article  CAS  PubMed  PubMed Central  Google Scholar 

Acuña-Castroviejo D, Escames G, Venegas C et al (2014) Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci 71:2997–3025. https://doi.org/10.1007/s00018-014-1579-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aiyegbusi OL, Hughes SE, Turner G et al (2021) Symptoms, complications and management of long COVID: a review. J R Soc Med 114:428–442. https://doi.org/10.1177/01410768211032850

Article  PubMed  PubMed Central  Google Scholar 

Akhtar A, Bawaneh A, Awwad M et al (2021) A longitudinal study of mental health before and during the COVID-19 pandemic in Syrian refugees. Eur J Psychotraumatology 12:1991651. https://doi.org/10.1080/20008198.2021.1991651

Article  Google Scholar 

Alghamdi BS (2018) The neuroprotective role of melatonin in neurological disorders. J Neurosci Res 96:1136–1149. https://doi.org/10.1002/jnr.24220

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ali AAH, Avakian GA, Von Gall C (2020) The role of purinergic receptors in the circadian system. Int J Mol Sci 21:3423. https://doi.org/10.3390/ijms21103423

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arruvito L, Sananez I, Seery V et al (2023) Purinergic signaling pathway in severe COVID-19. Curr Opin Pharmacol 70:102379. https://doi.org/10.1016/j.coph.2023.102379

Article  CAS  PubMed  Google Scholar 

Artigas L, Coma M, Matos-Filipe P et al (2020) In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm. PLoS ONE 15:e0240149. https://doi.org/10.1371/journal.pone.0240149

Article  CAS  PubMed  PubMed Central  Google Scholar 

Batista Simões JL, Sobierai LD, Pereira SM et al (2022) Therapeutic potential of P2X7 purinergic receptor modulation in the main organs affected by the COVID-19 cytokine storm. Curr Pharm des 28:1798–1814. https://doi.org/10.2174/1381612828666220713115906

Article  CAS  PubMed  Google Scholar 

Berridge KC (2007) The debate over dopamine’s role in reward: the case for incentive salience. Psychopharmacology 191:391–431. https://doi.org/10.1007/s00213-006-0578-x

Article  CAS  PubMed  Google Scholar 

Bertollo AG, Mingoti MED, Ignácio ZM (2024) Neurobiological mechanisms in the kynurenine pathway and major depressive disorder. Rev Neurosci. https://doi.org/10.1515/revneuro-2024-0065

Article  PubMed  Google Scholar 

Bodiga VL, Kudle MR, Bodiga S (2015) Silencing of PKC-α, TRPC1 or NF-κB expression attenuates cisplatin-induced ICAM-1 expression and endothelial dysfunction. Biochem Pharmacol 98:78–91. https://doi.org/10.1016/j.bcp.2015.08.101

Article  CAS  PubMed  Google Scholar 

Borbély AA, Daan S, Wirz-Justice A, Deboer T (2016) The two-process model of sleep regulation: a reappraisal. J Sleep Res 25:131–143. https://doi.org/10.1111/jsr.12371

Article  PubMed  Google Scholar 

Bremner J, Moazzami K, Wittbrodt M et al (2020) Diet, stress and mental health. Nutrients 12:2428. https://doi.org/10.3390/nu12082428

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burnstock G (2006) Purinergic signalling: purinergic signalling. Br J Pharmacol 147:S172–S181. https://doi.org/10.1038/sj.bjp.0706429

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burnstock G (2018) Purine and purinergic receptors. Brain Neurosci Adv 2:239821281881749. https://doi.org/10.1177/2398212818817494

Article  Google Scholar 

Burnstock G, Boeynaems J-M (2014) Purinergic signalling and immune cells. Purinergic Signal 10:529–564. https://doi.org/10.1007/s11302-014-9427-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burnstock G, Dale N (2015) Purinergic signalling during development and ageing. Purinergic Signal 11:277–305. https://doi.org/10.1007/s11302-015-9452-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cardinali DP, Brown GM, Reiter RJ, Pandi-Perumal SR (2020) Elderly as a high-risk group during COVID-19 pandemic: effect of circadian misalignment, sleep dysregulation and melatonin administration. Sleep Vigil 4:81–87. https://doi.org/10.1007/s41782-020-00111-7

Article  PubMed  PubMed Central  Google Scholar 

Cardinali DP, Brown GM, Pandi-Perumal SR (2022) Possible application of melatonin in long COVID. Biomolecules 12:1646. https://doi.org/10.3390/biom12111646

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cardoso TC, Pompeu TE, Silva CLM (2017) The P2Y1 receptor-mediated leukocyte adhesion to endothelial cells is inhibited by melatonin. Purinergic Signal 13:331–338. https://doi.org/10.1007/s11302-017-9565-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cekic C, Linden J (2016) Purinergic regulation of the immune system. Nat Rev Immunol 16:177–192. https://doi.org/10.1038/nri.2016.4

Article  CAS  PubMed  Google Scholar 

Chang EH, Carnevale D, Chavan SS (2023) Editorial: Understanding and targeting neuro-immune interactions within disease and inflammation. Front Immunol 14:1201669. https://doi.org/10.3389/fimmu.2023.1201669

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Liu Q, Guo D (2020) Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92:418–423. https://doi.org/10.1002/jmv.25681

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng F, Rao S, Mehra R (2020) COVID-19 treatment: combining anti-inflammatory and antiviral therapeutics using a network-based approach. Cleve Clin J Med. https://doi.org/10.3949/ccjm.87a.ccc037

Cho JH, Bhutani S, Kim CH, Irwin MR (2021) Anti-inflammatory effects of melatonin: a systematic review and meta-analysis of clinical trials. Brain Behav Immun 93:245–253. https://doi.org/10.1016/j.bbi.2021.01.034

Article  CAS  PubMed  PubMed Central  Google Scholar 

Da Silva GB, Manica D, Da Silva AP et al (2022) High levels of extracellular ATP lead to different inflammatory responses in COVID-19 patients according to the severity. J Mol Med 100:645–663. https://doi.org/10.1007/s00109-022-02185-4

Article  CAS  PubMed  Google Scholar 

Deng Q, Parker E, Wu C, et al (2024) Repurposing ketamine in the therapy of depression and depression-related disorders: recent advances and future potential. Aging Dis 0. https://doi.org/10.14336/AD.2024.0239

Di Virgilio F, Tang Y, Sarti AC, Rossato M (2020) A rationale for targeting the P2X7 receptor in coronavirus disease 19. Br J Pharmacol 177:4990–4994. https://doi.org/10.1111/bph.15138

Article  CAS  PubMed  PubMed Central  Google Scholar 

Domercq M, Brambilla L, Pilati E et al (2006) P2Y1 receptor-evoked glutamate exocytosis from astrocytes. J Biol Chem 281:30684–30696.